| Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension |
65 |
| A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis |
39 |
| Understanding the Bone in Cancer Metastasis |
31 |
| Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials |
30 |
| High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial |
28 |
| Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase Parallel Group Study |
26 |
| One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study |
24 |
| High-Fat Diet-Induced Obesity Promotes Expansion of Bone Marrow Adipose Tissue and Impairs Skeletal Stem Cell Functions in Mice |
24 |
| Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study |
23 |
| FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab |
19 |
| Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline |
19 |
| Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture Occur Early and Particularly Impact Postmenopausal Women |
19 |
| Role of Epigenomics in Bone and Cartilage Disease |
19 |
| Future Osteoporotic Fracture Risk Related to Lumbar Vertebral Trabecular Attenuation Measured at Routine Body CT |
19 |
| Diabetes and Deficits in Cortical Bone Density, Microarchitecture, and Bone Size: Framingham HR-pQCT Study |
18 |
| Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone |
18 |
| Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial |
17 |
| Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture |
17 |
| Relationship Between Bone Mineral Density T-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment |
17 |
| Probiotic Lactobacillus reuteri Prevents Postantibiotic Bone Loss by Reducing Intestinal Dysbiosis and Preventing Barrier Disruption |
16 |
| Subchondral Trabecular Rod Loss and Plate Thickening in the Development of Osteoarthritis |
16 |
| Sirt1 Promotes Osteogenic Differentiation and Increases Alveolar Bone Mass via Bmi1 Activation in Mice |
16 |
| The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017 |
16 |
| Fracture Risk After Gastric Bypass Surgery: A Retrospective Cohort Study |
15 |
| Comparative Analysis of the Radiology of Osteoporotic Vertebral Fractures in Women and Men: Cross-Sectional and Longitudinal Observations from the Canadian Multicentre Osteoporosis Study (CaMos) |
15 |
| The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report |
15 |
| Vitamin D Metabolism Revised: Fall of Dogmas |
15 |
| Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial |
15 |
| Estrogen Deficiency-Mediated M2 Macrophage Osteoclastogenesis Contributes to M1/M2 Ratio Alteration in Ovariectomized Osteoporotic Mice |
15 |
| The Effect of a Screening and Treatment Program for the Prevention of Fractures in Older Women: A Randomized Pragmatic Trial |
14 |
| Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase Single-Arm, International Trial |
14 |
| Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip FracturesA Post Hoc Analysis of the SCOOP Study |
14 |
| 25-Hydroxyvitamin D Threshold for the Effects of Vitamin D Supplements on Bone Density: Secondary Analysis of a Randomized Controlled Trial |
14 |
| Severely Impaired Bone Material Quality in Chihuahua Zebrafish Resembles Classical Dominant Human Osteogenesis Imperfecta |
14 |
| Alkaline Phosphatase: Discovery and Naming of Our Favorite Enzyme |
14 |
| Measures of Physical Performance and Muscle Strength as Predictors of Fracture Risk Independent of FRAX, Falls, and aBMD: A Meta-Analysis of the Osteoporotic Fractures in Men (MrOS) Study |
13 |
| High-Impact Mechanical Loading Increases Bone Material Strength in Postmenopausal WomenA 3-Month Intervention Study |
13 |
| Beclin1 Modulates Bone Homeostasis by Regulating Osteoclast and Chondrocyte Differentiation |
13 |
| Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of Bone |
13 |
| Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture Outcome |
13 |
| Bone-Forming and Antiresorptive Effects of Romosozumab in Postmenopausal Women With Osteoporosis: Bone Histomorphometry and Microcomputed Tomography Analysis After 2 and 12 Months of Treatment |
13 |
| Joint Association Analysis Identified 18 New Loci for Bone Mineral Density |
13 |
| The Ability of a Single BMD and Fracture History Assessment to Predict Fracture Over 25 Years in Postmenopausal Women: The Study of Osteoporotic Fractures |
13 |
| Obesity Decreases Hepatic 25-Hydroxylase Activity Causing Low Serum 25-Hydroxyvitamin D |
13 |
| Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study |
12 |
| Osteoporosis and Hip Fracture Risk From Routine Computed Tomography Scans: The Fracture, Osteoporosis, and CT Utilization Study (FOCUS) |
12 |
| PGC1 Organizes the Osteoclast Cytoskeleton by Mitochondrial Biogenesis and Activation |
12 |
| Activation of RANK/RANKL/OPG Pathway Is Involved in the Pathophysiology of Fibrous Dysplasia and Associated With Disease Burden |
12 |
| Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women |
12 |
| The Radiology of Osteoporotic Vertebral Fractures Revisited |
12 |
